早期手术与内镜优先策略对慢性胰腺炎患者疼痛的影响:ESCAPE随机临床试验
ESCAPE多中心随机优效性试验纳入88例伴主胰管扩张且近期开始使用阿片类药物的慢性胰腺炎疼痛患者,比较早期手术与内镜优先策略。
要点
- 早期手术较内镜优先策略降低慢性胰腺炎患者18个月整合疼痛评分。
- 早期手术组干预次数中位1次,显著少于内镜优先组的3次。
- 两组并发症(27% vs 25%)、死亡率(0% vs 0%)及生活质量无显著差异。
核心结论
- 在慢性胰腺炎伴主胰管扩张且近期启用阿片类药物的患者中,早期手术较内镜优先策略在18个月整合期内降低疼痛评分。
研究设计与样本
- ESCAPE为未设盲、多中心、随机临床优效性试验,涉及30家荷兰医院。
- 2011年4月至2016年9月纳入88例慢性胰腺炎、主胰管扩张且近期开始使用处方阿片类药物的患者,18个月随访至2018年3月。
- 44例随机至早期手术组(随机化后6周内行胰腺引流手术),44例随机至内镜优先组(药物治疗、必要时内镜含碎石及必要时手术)。
主要发现
- 治疗并发症(27% vs 25%)、死亡率(0% vs 0%)、住院次数、胰腺功能及生活质量组间无显著差异。
关键数值与推荐
- 主要终点为18个月整合的Izbicki疼痛评分(范围0-100,评分越高疼痛越重)。
- 治疗并发症27% vs 25%,死亡率0% vs 0%。
临床怎么用
- 对于慢性胰腺炎伴主胰管扩张且近期启用阿片类药物的严重疼痛患者,可考虑早期手术以降低18个月疼痛评分并减少干预次数。
- 早期手术与内镜优先策略在并发症、死亡率及生活质量方面无显著差异,决策时需结合患者具体情况。
局限性
- 研究为未设盲设计。
- 样本量88例,随访18个月,作者指出需进一步研究评估差异随时间持续性并重复研究结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: For patients with painful chronic pancreatitis, surgical treatment is postponed until medical and endoscopic treatment have failed. Observational studies have suggested that earlier surgery could mitigate disease progression, providing better pain control and preserving pancreatic function. OBJECTIVE: To determine whether early surgery is more effective than the endoscopy-first approach in terms of clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: The ESCAPE trial was an unblinded, multicenter, randomized clinical superiority trial involving 30 Dutch hospitals participating in the Dutch Pancreatitis Study Group. From April 2011 until September 2016, a total of 88 patients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started using prescribed opioids for severe pain (strong opioids for ≤2 months or weak opioids for ≤6 months) were included. The 18-month follow-up period ended in March 2018. INTERVENTIONS: There were 44 patients randomized to the early surgery group who underwent pancreatic drainage surgery within 6 weeks after randomization and 44 patients randomized to the endoscopy-first approach group who underwent medical treatment, endoscopy including lithotripsy if needed, and surgery if needed. MAIN OUTCOMES AND MEASURES: The primary outcome was pain, measured on the Izbicki pain score and integrated over 18 months (range, 0-100 [increasing score indicates more pain severity]). Secondary outcomes were pain relief at the end of follow-up; number of interventions, complications, hospital admissions; pancreatic function; quality of life (measured on the 36-Item Short Form Health Survey [SF-36]); and mortality. RESULTS: Among 88 patients who were randomized (mean age, 52 years; 21 (24%) women), 85 (97%) completed the trial. During 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, -12 points [95% CI, -22 to -2]; P = .02). Complete or partial pain relief at end of follow-up was achieved in 23 of 40 patients (58%) in the early surgery vs 16 of 41 (39%)in the endoscopy-first approach group (P = .10). The total number of interventions was lower in the early surgery group (median, 1 vs 3; P < .001). Treatment complications (27% vs 25%), mortality (0% vs 0%), hospital admissions, pancreatic function, and quality of life were not significantly different between early surgery and the endoscopy-first approach. CONCLUSIONS AND RELEVANCE: Among patients with chronic pancreatitis, early surgery compared with an endoscopy-first approach resulted in lower pain scores when integrated over 18 months. However, further research is needed to assess persistence of differences over time and to replicate the study findings. TRIAL REGISTRATION: ISRCTN Identifier: ISRCTN45877994.
引用
- Issa Y, Kempeneers MA, Bruno MJ, et al. Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial. JAMA. 2020. PMID: 31961419. doi:10.1001/jama.2019.20967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。